PD-L1 is a ligand often overexpressed by tumor cells and stromal cells in the tumor microenvironment, which binds to PD-1 to inhibit T-cell function.[67] Deregulation of T-cell inhibition as a core antitumor mechanism in immunotherapy. The gene discussed is CD274; the disease is neoplasm.